Stay informed with the latest litigation news. Explore now

IP Verse

Glenmark Pharmaceuticals Europe competitive analysis

Latest publications and patents of Glenmark Pharmaceuticals Europe New

Explore the latest publications and patents granted to Glenmark Pharmaceuticals Europe, showcasing their recent innovations and technological advancements.

Latest oppositions filed by Glenmark Pharmaceuticals Europe

Explore patent oppositions filed by Glenmark Pharmaceuticals Europe against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3578175
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023
EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAApr 19, 2023
EP2959894
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISOct 12, 2022
EP2817000
Oral Pharmaceutical Compositions Of Dabigatran EtexilateESTEVE PHARMACEUTICALSApr 14, 2022
EP2478907
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 14, 2022
EP2493466
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAMar 10, 2021
EP3395338
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 27, 2020
EP3260117
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENJan 16, 2020
EP3395339
Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 16, 2020
EP3395340
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 16, 2020

Latest PTAB cases involving Glenmark Pharmaceuticals Europe New

Discover the latest PTAB cases involving Glenmark Pharmaceuticals Europe, highlighting their recent legal challenges and patent disputes.

Top competitors of Glenmark Pharmaceuticals Europe

Top competitors of Glenmark Pharmaceuticals Europe based on patent oppositions.